It induces NF-κB activity and pro-inflammatory cytokine release via the ST2 pathway (12), and its expression is typically upregulated in chronic inflammatory conditions such as inflammatory bowel disease (IBD) and rheumatoid arthritis (13). The gene discussed is NFKB1; the disease is inflammatory bowel disease.